|
|
|
|
| LEADER |
00753nam a22002291a 4500 |
| 003 |
AR-BaBNM |
| 005 |
20251014100438.0 |
| 007 |
ta |
| 008 |
130830s1997 fr 000 0 |||||||||spa d |
| 020 |
|
|
|a 92-832-3001-9
|
| 035 |
|
|
|a 000162311
|
| 040 |
|
|
|a AR-BaBNM
|b spa
|e aacr
|
| 080 |
|
|
|a 616-006.6
|
| 245 |
0 |
0 |
|a Non-steroidal anti-inflamatory drugs
|
| 260 |
|
|
|a Lyon :
|b IARC,
|c 1997.
|
| 300 |
|
|
|a 202 p.
|
| 490 |
0 |
|
|a IARC Handbooks of Cancer Prevention ;
|v 1
|
| 500 |
|
|
|a views and expert opinions of an IARC Working Group on the Evaluation of Cancer Preventive Agents, Lyon, 2-8 April 1997
|
| 650 |
|
4 |
|a Neoplasmas
|9 6873
|
| 710 |
1 |
|
|a World Health Organization
|b International Agency for Research on Cancer IARC
|
| 942 |
|
|
|2 udc
|c LIBRO
|n 1
|
| 999 |
|
|
|c 155163
|d 155163
|